This is mainly related to YBX1, which inhibits ferroptosis via the YBX1-RNF115-DHODH signaling pathway in an m5C-dependent manner and promotes the progression of HCC (Li O. et al., 2025). Here, YBX1 is linked to hepatocellular carcinoma.